[1]
|
Struhl, K. (2007) Transcriptional Noise and the Fidelity of Initiation by RNA Polymerase II. Nature Structural & Molecular Biology, 14, 103-105. https://doi.org/10.1038/nsmb0207-103
|
[2]
|
Mathieu, E.-L., Belhocine, M., Dao, L.T.M., Puthier, D. and Spicuglia, S. (2014) Functions of lncRNA in Development and Diseases. Medical Sciences (Paris), 30, 790-796. https://doi.org/10.1051/medsci/20143008018
|
[3]
|
Peng, W.X., Koirala, P. and Mo, Y.Y. (2017) LncRNA-Mediated Regulation of Cell signaling in Cancer. Oncogene, 36, 5661-5667. https://doi.org/10.1038/onc.2017.184
|
[4]
|
Chureau, C., Chantalat, S., Romito, A., Galvani, A., Duret, L., Avner, P., et al. (2011) FTX Is a Non-Coding RNA Which Affects Xist Expression and Chromatin Structure within the X-Inactivation Center Region. Human Molecular Genetics, 20, 705-718. https://doi.org/10.1093/hmg/ddq516
|
[5]
|
Li, X., Zhao, Q., Qi, J., Wang, W., Zhang, D., Li, Z., et al. (2018) lncRNA Ftx Promotes Aerobic Glycolysis and Tumor Progression through the PPARγ Pathway in Hepatocellular Carcinoma. International Journal of Oncolog, 53, 551-566. https://doi.org/10.3892/ijo.2018.4418
|
[6]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[7]
|
Jin, S., He, J., Zhou, Y., Wu, D., Li, J., Gao, W., et al. (2020) LncRNA FTX activates FOXA2 Expression to Inhibit Non-Small-Cell Lung Cancer Proliferation and Metastasis. Journal of Cellular and Molecular Medicine, 24, 4839-4849.
https://doi.org/10.1111/jcmm.15163
|
[8]
|
Huo, X., Wang, H., Huo, B., Wang, L., Yang, K., Wang, J., et al. (2020) FTX Contributes to Cell Proliferation and Migration in Lung Adenocarcinoma via Targeting miR-335-5p/NUCB2 Axis. Cancer Cell International, 20, Article No. 89. https://doi.org/10.1186/s12935-020-1130-5
|
[9]
|
Brody, H. (2015) Colorectal Cancer. Nature, 521, S1. https://doi.org/10.1038/521S1a
|
[10]
|
Zhao, K., Ye, Z., Li, Y., Li, C., Yang, X., Chen, Q., et al. (2020) LncRNA FTX Contributes to the Progression of Colorectal Cancer Through Regulating miR-192-5p/EIF5A2 Axis. OncoTargets and Therapy, 13, 2677-2688.
https://doi.org/10.2147/OTT.S241011
|
[11]
|
Chen, G.Q., Liao, Z.M., Liu, J., Li, F., Huang, D. and Zhou, Y.D. (2021) LncRNA FTX Promotes Colorectal Cancer Cells Migration and Invasion by miRNA-590-5p/RBPJ Axis. Biochemical Genetics, 59, 560-573.
https://doi.org/10.1007/s10528-020-10017-8
|
[12]
|
Yang, Y., Zhang, J., Chen, X., Xu, X., Cao, G., Li, H., et al. (2018) LncRNA FTX Sponges miR-215 and Inhibits Phosphorylation of Vimentin for Promoting Colorectal Cancer Progression. Gene Therapy, 25, 321-330.
https://doi.org/10.1038/s41434-018-0026-7
|
[13]
|
Huang, S., Zhu, X., Ke, Y., Xiao, D., Liang, C., Chen, J., et al. (2020) LncRNA FTX Inhibition Restrains Osteosarcoma Proliferation and Migration via Modulating miR-320a/TXNRD1. Cancer Biology & Therapy, 21, 379-387.
https://doi.org/10.1080/15384047.2019.1702405
|
[14]
|
Li, B., Ren, P. and Wang, Z. (2018) Long Non-Coding RNA FTX Promotes Osteosarcoma Progression via the Epithelial to Mesenchymal Transition Mechanism and Is Associated with Poor Prognosis in Patients with Osteosarcoma. International Journal of Clinical and Experimental Pathology, 11, 4503-4511.
|
[15]
|
Chen, H., Liu, T., Ouyang, H., Lin, S., Zhong, H., Zhang, H., et al. (2020) Upregulation of FTX Promotes Osteosarcoma Tumorigenesis by Increasing SOX4 Expression via miR-214-5p. OncoTargets and Therapy, 13, 7125-7136.
https://doi.org/10.2147/OTT.S238070
|
[16]
|
Zhu, L., Jia, R., Zhang, J., Li, X., Qin, C. and Zhao, Q. (2020) Quantitative Proteomics Analysis Revealed the Potential Role of lncRNA Ftx in Promoting Gastric Cancer Progression. PROTEOMICS: Clinical Applications, 14, e1900053.
https://doi.org/10.1002/prca.201900053
|
[17]
|
Zhang, F., Wang, X.S., Tang, B., Li, P.A., Wen, Y. and Yu, P.W. (2020) Long Non-Coding RNA FTX Promotes Gastric Cancer Progression by Targeting miR-215. European Review for Medical and Pharmacological Sciences, 24, 3037-3048. https://doi.org/10.26355/eurrev_202003_20668
|
[18]
|
Li, H., Yao, G., Zhai, J., Hu, D. and Fan, Y. (2019) LncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis. OncoTargets and Therapy, 12, 11701-11713. https://doi.org/10.2147/OTT.S220998
|
[19]
|
Liu, F., Yuan, J.H., Huang, J.F., Yang, F., Wang, T.T., Ma, J.Z., et al. (2016) Long Noncoding RNA FTX Inhibits Hepatocellular Carcinoma Proliferation and Metastasis by Binding MCM2 and miR-374a. Oncogene, 35, 5422-5434.
https://doi.org/10.1038/onc.2016.80
|
[20]
|
龙翔宇, 周伟, 江波, 周超, 邬昊, 刘彦, 等. 长链非编码RNA FTX靶向miR-21-3p对肝癌细胞生长侵袭和迁移调控作用[J]. 中华肿瘤防治杂志, 2019, 26(17): 1244-1250.
|
[21]
|
Liu, Z., Dou, C., Yao, B., Xu, M., Ding, L., Wang, Y., et al. (2016) FTX Non Coding RNA-Derived miR-545 Promotes Cell Proliferation by Targeting RIG-I in Hepatocellular Carcinoma. Oncotarget, 7, 25350-25365.
https://doi.org/10.18632/oncotarget.8129
|
[22]
|
Li, S., Zhang, Q., Liu, W. and Zhao, C. (2021) Silencing of FTX Suppresses Pancreatic Cancer Cell Proliferation and Invasion by Upregulating miR-513b-5p. BMC cancer, 21, Article No. 290.
https://doi.org/10.1186/s12885-021-07975-6
|